Table 2.

Multivariate ORs for prevalence, treatment and lack of control of hypertension

Determinants	ABPM		Pre-HD BP		Post-HD BP
	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Prevalence of hypertension
Age, years	0.98 (0.96–1.00)	0.08
Serum albumin, g/dl	1.76 (0.90–3.46)	0.1
Aspirin use, yes/no	1.85 (0.98–3.51)	0.06			2.01 (0.97–4.17)	0.06
BMI	0.91 (0.87–0.97)	<0.01			0.92 (0.86–0.98)	<0.01
Dialysis duration		0.03		0.01		<0.001
<1 year	1.00 (réf. cat.)		1.00 (réf. cat.)		1.00 (réf. cat.)
1–4 years	0.48 (0.22–1.02)	0.06	0.21 (0.06–0.77)	0.02	0.30 (0.12–0.79)	0.01
≥4 years	0.36 (0.17–0.78)	0.01	0.14 (0.04–0.51)	<0.01	0.15 (0.06–0.39)	<0.001
Epoetin use, yes/no	2.54 (1.35–4.77)	<0.01	2.06 (0.91–4.69)	0.08	2.16 (1.06–4.40)	0.03
LR χ2	30.76		16.00		29.42
Pseudo r2	0.10		0.08		0.11
Treatment of hypertension
Aspirin use, yes/no	2.50 (1.11–5.64)	0.03	2.43 (1.30–4.53)	<0.01	2.08 (1.05–4.09)	0.03
BMI			0.93 (0.88–0.97)	<0.01	0.95 (0.90–1.01)	0.08
Epoetin use, yes/no			2.17 (1.17–4.03)	0.01	2.02 (1.02–3.99)	0.04
Vitamin D receptor activator use, yes/no	0.39 (0.19–0.82)	0.01	0.51 (0.27–0.95)	0.03	0.48 (0.24–0.94)	0.03
LR χ2	10.88		23.71		13.11
Pseudo r2	0.05		0.07		0.05
Lack of control of hypertension
Serum albumin, g/dl	0.38 (0.20–0.72)	<0.01
BMI			0.91 (0.86–0.97)	<0.01
Epoetin use, yes/no					1.88 (1.05–3.34)	0.03
Antihypertensive use		0.02				<0.01
1 antihypertensive	1.00 (réf. cat.)				1.00 (réf. cat.)
2 antihypertensives	1.53 (0.75–3.13)	0.2			3.07 (1.46–6.45)	<0.01
3 antihypertensives	2.49 (1.10–5.64)	0.03			3.76 (1.61–8.77)	<0.01
≥4 antihypertensives	3.21 (1.41–7.30)	<0.01			4.52 (1.92–10.67)	<0.001
History of diabetes mellitus, yes/no			3.46 (1.72–6.99)	<0.001
Hemoglobin, g/dl			0.77 (0.60–0.97)	0.03
Urea reduction ratio, %					1.04 (1.00–1.09)	0.04
Vitamin D receptor activator use, yes/no	1.88 (1.02–3.46)	0.04
LR χ2	23.71		21.36		22.09
Pseudo r2	0.07		0.08		0.07